ECMO Perfusion Basics
On this page
Direct answer
Take the bypass circuit out of the theatre, hard-wire it to a patient for days, and it becomes extracorporeal membrane oxygenation: a centrifugal pump and polymethylpentene oxygenator in a closed, reservoir-free circuit, veno-arterial (VA) for cardiac or cardiopulmonary support — draining the right atrium, returning oxygenated blood to a femoral or axillary artery — or veno-venous (VV) for pure respiratory support, both cannulae in the venous system. Anticoagulation is deliberately lighter than bypass: unfractionated heparin monitored to ACT 180-220 seconds or, increasingly preferred, anti-Xa 0.3-0.7 IU/mL or aPTT 50-90 seconds, because the enemy over days is both clot and bleed. VA flows for full support in adults reach 3-6 L/min; weaning is a staged trial, not a switch-off.
What you must remember
- Configuration logic: VA supports circulation and lungs (drainage from right atrium via femoral or IJ vein, return to femoral/axillary artery, or central cannulation); VV supports gas exchange only — the heart must be structurally adequate.
- Anticoagulation targets on ECMO: ACT 180-220 seconds, or anti-Xa 0.3-0.7 IU/mL, or aPTT 50-90 seconds; anti-Xa is increasingly preferred because ACT is distorted by haemodilution, thrombocytopenia and hypofibrinogenaemia over long runs.
- Circuit anatomy versus CPB: closed circuit, no open reservoir, centrifugal (magnet-driven) pump, polymethylpentene membrane oxygenator, bladder or pressure sensor protecting against drainage collapse.
- VA specifics: adult full-support flows commonly 3-6 L/min; distal perfusion catheter in the femoral artery guards the perfused limb against ischaemia; pulse pressure tells you how much native heart function remains.
- Harlequin (north-south) syndrome: in femoral VA ECMO with recovering lungs, deoxygenated native left-ventricular output perfuses the upper body while well-oxygenated circuit blood feeds the lower — monitor the right radial artery gas and NIRS.
- VV specifics: hypoxaemia indication (severe ARDS, refractory), double-lumen or dual-site cannulation, recirculation is its characteristic inefficiency (fresh return sucked straight back into the drainage cannula).
- Daily vigilance and weaning: inspect the circuit for fibrin strands, clots and rising oxygenator delta pressures, with plasma free haemoglobin for haemolysis; wean VA by reducing flow in steps to roughly 1-1.5 L/min under echo, and VV by sweeping down to air while watching gases.
- ECPR: rapid-deployment VA ECMO during cardiac arrest — cannulation during compressions, the modern fusion of resuscitation and perfusion.
A VA run, first day to trial
A 58-year-old with post-infarct cardiogenic shock goes on femoro-femoral VA ECMO in the catheterisation laboratory: 25 Fr multistage drainage venous cannula, 19 Fr arterial return, distal perfusion catheter inserted down the femoral artery immediately — the leg is the first thing ECMO sacrifices. Flow set to 3.8 L/min; ACT held near 200 with a heparin infusion; sweep 4 litres of oxygen to keep PaCO2 near 40. Day 2, the right radial artery gas (deliberately sampled above the ECMO return) shows PaO2 55 with the circuit post-oxygenator reading 300 — the Harlequin pattern: recovering native lungs are not, and hypoxic native blood is feeding the brain and coronaries. Management per protocol: optimise native lung ventilation and consider a more cephalad or central return strategy. Day 5, on milrinone and minimal pressors, flow is dropped in steps to 1.2 L/min over 3 hours with echo showing an ejecting, non-distending left ventricle, pulsatility returning — the trial is passed and decannulation is planned. That arc — rescue, vigilance, staged withdrawal — is ECMO perfusion in one case.
How the exam frames it
The guaranteed question is "compare VA and VV ECMO", and the strong answer organises by what each supports, where the cannulae sit, and what each cannot do (VV cannot support the circulation; femoral VA can steal the upper body's oxygen). The second certainty is anticoagulation: quoting ACT 180-220 is baseline competence; adding that anti-Xa 0.3-0.7 IU/mL is displacing ACT because ACT drifts unreliable over long runs is what distinguishes training from memorisation. Indian context earns viva credit: ECMO programmes expanded substantially after the 2009-2010 pandemic influenza experience, major centres now run ECPR and retrieval cannulation, and cost shapes disposables decisions. The trap question remains "ECMO is just long bypass" — the marks go to the differences: closed circuit, lighter anticoagulation, awake patients, days-to-weeks horizon, organ-recovery (or bridge) intent.
Frequently asked questions
Which ECMO configuration supports the circulation itself?
VA ECMO — venous drainage with arterial return — supports both heart and lungs; VV ECMO supports gas exchange only and requires adequate native cardiac function.
What anticoagulation targets are used during ECMO?
Unfractionated heparin to ACT 180-220 seconds, or increasingly anti-Xa 0.3-0.7 IU/mL or aPTT 50-90 seconds, with anti-Xa preferred for reliability over long runs.
What is Harlequin syndrome on femoral VA ECMO?
Differential hypoxia — poorly oxygenated native left-ventricular output supplies the brain and heart while well-oxygenated circuit blood perfuses the lower body; detect via right radial gas or NIRS.
Why is a distal perfusion catheter placed during femoral cannulation?
The large arterial return cannula can occlude limb perfusion; the distal catheter perfuses the leg distally and prevents ischaemic complications.
How is VA ECMO weaning performed?
Flow is reduced in stages to around 1-1.5 L/min under echocardiographic and haemodynamic monitoring; sustained native circulation and improving pulse pressure indicate readiness to decannulate.